228 related articles for article (PubMed ID: 37533434)
1. Mapping the tumor microenvironment in clear cell renal carcinoma by single-cell transcriptome analysis.
Wang Y; Wang Y; Liu B; Gao X; Li Y; Li F; Zhou H
Front Genet; 2023; 14():1207233. PubMed ID: 37533434
[No Abstract] [Full Text] [Related]
2. Boosting Clear Cell Renal Carcinoma-Specific Drug Discovery Using a Deep Learning Algorithm and Single-Cell Analysis.
Wang Y; Chen X; Tang N; Guo M; Ai D
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612943
[TBL] [Abstract][Full Text] [Related]
3. The integrate profiling of single-cell and spatial transcriptome RNA-seq reveals tumor heterogeneity, therapeutic targets, and prognostic subtypes in ccRCC.
Zhang Y; Huang X; Yu M; Zhang M; Zhao L; Yan Y; Zhang L; Wang X
Cancer Gene Ther; 2024 Mar; ():. PubMed ID: 38480978
[TBL] [Abstract][Full Text] [Related]
4. High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints.
Raghubar AM; Matigian NA; Crawford J; Francis L; Ellis R; Healy HG; Kassianos AJ; Ng MSY; Roberts MJ; Wood S; Mallett AJ
NPJ Precis Oncol; 2023 Sep; 7(1):88. PubMed ID: 37696903
[TBL] [Abstract][Full Text] [Related]
5. Distinct spatial landscapes in clear-cell renal cell carcinoma as revealed by whole transcriptome analysis.
López JI; Hogan MF; Sutton B; Church SE; Angulo JC; Nunes-Xavier CE
Immunooncol Technol; 2024 Mar; 21():100690. PubMed ID: 38292905
[TBL] [Abstract][Full Text] [Related]
6. Molecular subtyping and characterization of clear cell renal cell carcinoma by tumor differentiation trajectories.
Pan XW; Chen WJ; Xu D; Guan WB; Li L; Chen JX; Chen WJ; Dong KQ; Ye JQ; Gan SS; Zhou W; Cui XG
iScience; 2023 Dec; 26(12):108370. PubMed ID: 38034348
[TBL] [Abstract][Full Text] [Related]
7. Immunometabolic coevolution defines unique microenvironmental niches in ccRCC.
Tang C; Xie AX; Liu EM; Kuo F; Kim M; DiNatale RG; Golkaram M; Chen YB; Gupta S; Motzer RJ; Russo P; Coleman J; Carlo MI; Voss MH; Kotecha RR; Lee CH; Tansey W; Schultz N; Hakimi AA; Reznik E
Cell Metab; 2023 Aug; 35(8):1424-1440.e5. PubMed ID: 37413991
[TBL] [Abstract][Full Text] [Related]
8. The utilization of single-cell sequencing technology in investigating the immune microenvironment of ccRCC.
Liu Y; Wu G
Front Immunol; 2023; 14():1276658. PubMed ID: 38090562
[TBL] [Abstract][Full Text] [Related]
9. Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse model.
Wang Y; Cho JW; Kastrunes G; Buck A; Razimbaud C; Culhane AC; Sun J; Braun DA; Choueiri TK; Wu CJ; Jones K; Nguyen QD; Zhu Z; Wei K; Zhu Q; Signoretti S; Freeman GJ; Hemberg M; Marasco WA
iScience; 2024 Feb; 27(2):108879. PubMed ID: 38327771
[TBL] [Abstract][Full Text] [Related]
10. Exploration of immune cell heterogeneity by single-cell RNA sequencing and identification of secretory leukocyte protease inhibitor as an oncogene in pancreatic cancer.
Ai B; Liang Y; Yan T; Lei Y
Environ Toxicol; 2024 Mar; ():. PubMed ID: 38476085
[TBL] [Abstract][Full Text] [Related]
11. Single-Cell Analysis Reveals Spatial Heterogeneity of Immune Cells in Lung Adenocarcinoma.
Wang Y; Li X; Peng S; Hu H; Wang Y; Shao M; Feng G; Liu Y; Bai Y
Front Cell Dev Biol; 2021; 9():638374. PubMed ID: 34513820
[TBL] [Abstract][Full Text] [Related]
12. STING agonist, SMA-2, inhibits clear cell renal cell carcinoma through improving tumor microenvironment.
Wang W; Zhang F; Hu Y; Liu G
Mol Cell Biochem; 2024 Apr; ():. PubMed ID: 38592428
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the malignant cells and microenvironment of infantile fibrosarcoma via single-cell RNA sequencing.
Li Y; Zhang Q; Yang R; Zhan Y; Li Z; Dai S; Chen D; Chen L; Ruggiero A; Ye C; Lu Y; Zhou E; Dong R; Dong K
Transl Pediatr; 2024 Apr; 13(4):596-609. PubMed ID: 38715675
[TBL] [Abstract][Full Text] [Related]
14. Large-scale analysis of cell-cell communication reveals angiogenin-dependent tumor progression in clear cell renal cell carcinoma.
Massenet-Regad L; Poirot J; Jackson M; Hoffmann C; Amblard E; Onodi F; Bouhidel F; Djouadou M; Ouzaid I; Xylinas E; Medvedovic J; Soumelis V
iScience; 2023 Dec; 26(12):108367. PubMed ID: 38025776
[TBL] [Abstract][Full Text] [Related]
15. Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma.
Schneider F; Kaczorowski A; Jurcic C; Kirchner M; Schwab C; Schütz V; Görtz M; Zschäbitz S; Jäger D; Stenzinger A; Hohenfellner M; Duensing S; Duensing A
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894418
[TBL] [Abstract][Full Text] [Related]
16. Application of single-cell sequencing to the research of tumor microenvironment.
Chen S; Zhou Z; Li Y; Du Y; Chen G
Front Immunol; 2023; 14():1285540. PubMed ID: 37965341
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Single-Cell RNA-Sequencing of Primary and Metastatic Clear Cell Renal Cell Carcinoma.
Alchahin AM; Tsea I; Baryawno N
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835428
[TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing reveals the cellular and molecular heterogeneity of treatment-naïve primary osteosarcoma in dogs.
Ammons D; Hopkins L; Cronise K; Kurihara J; Regan D; Dow S
Res Sq; 2023 Aug; ():. PubMed ID: 37609233
[TBL] [Abstract][Full Text] [Related]
19. Examining heterogeneity of stromal cells in tumor microenvironment based on pan-cancer single-cell RNA sequencing data.
Wang W; Wang L; She J; Zhu J
Cancer Biol Med; 2021 Aug; 19(1):30-42. PubMed ID: 34398535
[TBL] [Abstract][Full Text] [Related]
20. Deconstructing intratumoral heterogeneity through multiomic and multiscale analysis of serial sections.
Schupp PG; Shelton SJ; Brody DJ; Eliscu R; Johnson BE; Mazor T; Kelley KW; Potts MB; McDermott MW; Huang EJ; Lim DA; Pieper RO; Berger MS; Costello JF; Phillips JJ; Oldham MC
bioRxiv; 2024 Mar; ():. PubMed ID: 37645893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
